LogicBio Therapeutics, Inc. (NASDAQ:LOGC)

About the company

LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

41

$1.00M

Total Revenue

41

Employees

$168.59M

Market Capitalization

-3.96

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$M

Net Margin (in %)

Total net margin

$M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 396892.01 82729.00 6.38 23.13 20.75
Merck & Co., Inc. MRK 203843.05 48081.00 7.65 20.11 21.10
Pfizer Inc. PFE 201496.53 50660.00 3.05 12.76 31.17
Eli Lilly & Co. LLY 151883.10 23087.00 51.54 26.77 23.97
AbbVie, Inc. ABBV 149112.32 34057.00 -23.87 17.78 24.65
Bristol Myers Squibb Co. BMY 108080.63 31006.00 2.62 91.89 3.08
Repligen Corp. RGEN 6679.47 286.00 6.40 291.04 8.11
Reata Pharmaceuticals, Inc. RETA 4635.12 20.00 21.96 -14.91 -150.30
Nektar Therapeutics NKTR 4340.16 137.00 3.39 -9.45 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3972.28 1.00 36.73 -6.08 None
Allakos, Inc. ALLK 3384.00 None 7.35 -36.18 None
OPKO Health, Inc. OPK 2481.67 891.00 1.76 -8.49 -32.92
Karuna Therapeutics, Inc. KRTX 2434.12 None 6.36 -60.01 None
ADC Therapeutics SA ADCT 2287.98 2.00 26.99 -19.62 None
Turning Point Therapeutics, Inc. TPTX 2274.12 None 6.84 -19.03 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2106.06 None 9.30 -5.05 None
Principia Biopharma, Inc. PRNB 1944.60 30.00 6.92 -27.67 -242.01
IGM Biosciences, Inc. IGMS 1922.00 None 8.47 -35.43 None
Springworks Therapeutics, Inc. SWTX 1652.06 None 5.37 -26.50 None
Y-mAbs Therapeutics, Inc. YMAB 1473.34 None 9.03 -15.99 None
Zymeworks, Inc. ZYME 1289.82 26.00 2.68 -7.60 -629.37
Tricida, Inc. TCDA 1277.43 None 6.57 -6.05 None
Kiniksa Pharmaceuticals Ltd. KNSA 1209.45 None 6.26 -10.00 None
Akcea Therapeutics, Inc. AKCA 1188.25 341.00 2.44 -42.24 -8.59
Odonate Therapeutics, Inc. ODT 1147.24 None 9.40 -10.20 None
Arcutis Biotherapeutics, Inc. ARQT 1070.78 None 4.56 -17.12 None
Phibro Animal Health Corp. PAHC 1057.80 818.00 5.34 28.67 4.49
Akero Therapeutics, Inc. AKRO 1020.51 None 10.32 -20.11 None
Athenex, Inc. ATNX 938.34 123.00 5.76 -8.72 -87.86
Constellation Pharmaceuticals, Inc. CNST 899.52 None 4.23 -9.69 None
Gossamer Bio, Inc. GOSS 811.30 None 3.29 -4.08 None
Phathom Pharmaceuticals, Inc. PHAT 781.50 None 4.34 -2.87 None
G1 Therapeutics, Inc. GTHX 780.52 1.00 3.38 -5.95 None
Quanterix Corp. QTRX 768.96 60.00 6.78 -17.58 -71.52
Arcturus Therapeutics Holdings, Inc. ARCT 702.00 19.00 65.06 -25.23 -151.34
Krystal Biotech, Inc. KRYS 681.87 None 3.98 -32.88 None
Amneal Pharmaceuticals, Inc. AMRX 680.89 1679.00 4.69 -3.13 -11.85
Applied Therapeutics, Inc. APLT 675.62 14.00 4.36 -13.71 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Oric Pharmaceuticals, Inc. ORIC 647.64 None -7.03 -21.42 None
Aprea Therapeutics, Inc. APRE 602.91 None 5.34 -17.83 None
Keros Therapeutics, Inc. KROS 561.60 8.00 -25.37 -26.44 -285.35
Oyster Point Pharma, Inc. OYST 526.89 None 5.29 -9.16 None
SIGA Technologies, Inc. SIGA 482.16 19.00 5.39 -24.50 -94.00
Mirum Pharmaceuticals, Inc. MIRM 473.75 None 3.08 -6.99 None
Biospecifics Technologies Corp. BSTC 469.74 40.00 3.81 20.09 61.80
89bio, Inc. ETNB 452.06 None 5.58 -7.00 None
Satsuma Pharmaceuticals, Inc. STSA 443.87 None 4.37 -12.20 None
Fulcrum Therapeutics, Inc. FULC 407.33 1.00 6.86 -5.90 None
Ocular Therapeutix, Inc. OCUL 401.76 6.00 -49.24 -4.38 None
DURECT Corp. DRRX 398.04 28.00 30.57 -16.46 -82.94
Imara, Inc. IMRA 384.54 None 3.71 -10.93 None
Relmada Therapeutics, Inc. RLMD 377.82 0.00 5.63 -31.56 -877.66
TCR2 Therapeutics, Inc. TCRR 376.08 None 2.57 -37.31 None
Kala Pharmaceuticals, Inc. KALA 369.72 6.00 4.04 -4.03 None
Crinetics Pharmaceuticals, Inc. CRNX 365.04 1.00 4.61 -6.26 -447.78
Ovid Therapeutics, Inc. OVID 332.55 None 7.86 -5.10 None
Osmotica Pharmaceuticals Plc OSMT 332.37 232.00 2.52 -1.21 -115.44
AMAG Pharmaceuticals, Inc. AMAG 285.26 321.00 1.09 -0.77 -115.05
IDEAYA Biosciences, Inc. IDYA 284.00 None 4.32 -6.51 None
HOOKIPA Pharma, Inc. HOOK 275.34 13.00 2.49 -6.09 -333.02
Urovant Sciences Ltd. UROV 268.20 None -4.76 -1.85 None
Aeglea Biotherapeutics, Inc. AGLE 263.01 4.00 8.30 -3.28 -523.27
Spero Therapeutics, Inc. SPRO 255.74 12.00 3.37 -3.14 -656.72
Galera Therapeutics, Inc. GRTX 214.50 None 4.01 -3.26 None
KalVista Pharmaceuticals, Inc. KALV 208.08 13.00 2.46 -7.05 -229.44
Sutro Biopharma, Inc. STRO 204.70 41.00 3.89 -3.36 -148.06
Veru, Inc. VERU 203.45 39.00 6.96 -20.87 -25.53
Verrica Pharmaceuticals, Inc. VRCA 198.00 None 3.62 -6.49 None
Lannett Co., Inc. LCI 195.32 542.00 0.67 -6.42 -5.77
Kaleido Biosciences, Inc. KLDO 191.10 None 6.78 -2.61 None
LogicBio Therapeutics, Inc. LOGC 168.59 1.00 5.09 -3.96 None
Protara Therapeutics, Inc. TARA 156.24 None 2.35 -10.13 None
Avenue Therapeutics, Inc. ATXI 153.60 532.00 28.24 -10.55 26.69
Liquidia Technologies, Inc. LQDA 147.40 8.00 11.55 -2.99 -602.17
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
scPharmaceuticals, Inc. SCPH 140.41 119.00 3.59 -4.48 -27.05
PhaseBio Pharmaceuticals, Inc. PHAS 140.07 2.00 2.60 -2.93 None
Gritstone Oncology, Inc. GRTS 139.68 4.00 1.25 -1.34 None
Ayala Pharmaceuticals, Inc. AYLA 137.52 3.00 -3.24 -6.66 -679.19
Cyclerion Therapeutics, Inc. CYCN 134.19 6.00 1.69 -1.29 None
Lyra Therapeutics, Inc. LYRA 133.92 1.00 -1.14 -8.03 -491.16
Harrow Health, Inc. HROW 132.86 51.00 8.52 -5.38 -47.54
Evelo Biosciences, Inc. EVLO 130.88 None 4.81 -1.49 None
Mustang Bio, Inc. MBIO 123.20 None 2.88 -2.50 None
TFF Pharmaceuticals, Inc. TFFP 122.55 None 4.74 -3.16 None
Immunic, Inc. IMUX 121.10 None 3.56 -55.05 None
Aquestive Therapeutics, Inc. AQST 115.50 49.00 -6.65 -1.64 -139.64
NeuBase Therapeutics, Inc. NBSE 111.16 None 46.71 -2.49 None
Corvus Pharmaceuticals, Inc. CRVS 110.49 None 1.77 -2.34 None
Evolus, Inc. EOLS 94.50 45.00 1.69 -0.93 -217.51
Trevi Therapeutics, Inc. TRVI 91.35 None 1.94 -3.11 None
Eton Pharmaceuticals, Inc. ETON 90.54 1.00 9.86 -4.53 None
Milestone Pharmaceuticals, Inc. MIST 86.50 None 0.85 -1.39 None
Xeris Pharmaceuticals, Inc. XERS 79.24 4.00 3.93 -0.61 None
EyePoint Pharmaceuticals, Inc. EYPT 77.93 26.00 5.50 -1.59 -196.30
Clearside Biomedical, Inc. CLSD 68.88 6.00 8.84 -3.91 -293.61
Navidea Biopharmaceuticals, Inc. NAVB 67.83 1.00 -49.88 -6.14 -65.13
Checkpoint Therapeutics, Inc. CKPT 66.00 2.00 5.69 -2.84 -949.53
Baudax Bio, Inc. BXRX 60.66 None -1.65 -0.86 None
Assertio Therapeutics, Inc. ASRT 60.29 192.00 1.05 -0.37 -83.99
Aridis Pharmaceuticals, Inc. ARDS 59.67 1.00 -24.56 -2.04 -851.00
BiomX, Inc. PHGE 58.96 None 1.55 -1.37 None
Genprex, Inc. GNPX 56.24 None 4.77 -4.11 None
Aerpio Pharmaceuticals, Inc. ARPO 51.66 20.00 1.56 -2.74 -51.58
Moleculin Biotech, Inc. MBRX 49.22 None 4.28 -5.35 None
Menlo Therapeutics, Inc. MNLO 46.98 2.00 3.95 -0.50 -483.51
Edesa Biotech, Inc. EDSA 42.39 0.00 6.04 -0.45 -395.23
Eyenovia, Inc. EYEN 42.08 None 4.24 -2.05 None
Annovis Bio, Inc. ANVS 41.58 None 3.81 -33.00 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Adamis Pharmaceuticals Corp. ADMP 35.44 22.00 1.36 -1.20 -140.33
AgeX Therapeutics, Inc. AGE 34.05 2.00 -44.80 -2.80 -658.11
Mannatech, Inc. MTEX 32.90 156.00 1.39 7.41 3.45
Allena Pharmaceuticals, Inc. ALNA 32.66 None 4.30 -0.75 None
Citius Pharmaceuticals, Inc. CTXR 32.13 None 2.38 -1.86 None
Acer Therapeutics, Inc. ACER 31.10 3.00 2.27 -1.19 -274.69
Oncternal Therapeutics, Inc. ONCT 30.16 3.00 3.87 -1.20 -225.89
CNS Pharmaceuticals, Inc. CNSP 27.52 None 4.78 -5.06 None
Hoth Therapeutics, Inc. HOTH 27.40 None 7.61 -3.04 None
Millendo Therapeutics, Inc. MLND 25.50 0.00 0.60 -0.54 None
Aileron Therapeutics, Inc. ALRN 24.46 None 3.49 -0.92 None
Daré Bioscience, Inc. DARE 23.94 1.00 10.50 -1.43 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Spring Bank Pharmaceuticals, Inc. SBPH 22.40 0.00 0.85 -0.86 None
ProPhase Labs, Inc. PRPH 18.36 9.00 1.66 -6.12 -31.15
Novan, Inc. NOVN 14.62 5.00 -3.36 -0.46 -602.34
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
PDS Biotechnology Corp. PDSB 14.28 None 1.58 -0.56 None
Adial Pharmaceuticals, Inc. ADIL 13.65 None 3.33 -1.80 None
Titan Pharmaceuticals, Inc. TTNP 11.20 4.00 4.67 -0.62 -437.91
Novus Therapeutics, Inc. NVUS 7.20 None 0.62 -0.34 None
Brickell Biotech, Inc. BBI 4.22 5.00 1.38 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

LogicBio Therapeutics Inc.

6d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Hedge Funds Cutting Exposure To LogicBio Therapeutics, Inc. (LOGC)

1mon ago, source: YAHOO!

LogicBio Therapeutics, Inc. (NASDAQ:LOGC) shareholders have witnessed a decrease in activity from the world's largest hedge funds of late. LOGC was in 4 hedge funds' portfolios at the end of March.

Immunogen Inc.

7d ago, source: MarketWatch

Inc. He is also on the board of Akebia Therapeutics, Inc., American Cancer Society New England Division, Inc. and LogicBio Therapeutics, Inc. Mr. Enyedy previously occupied the position of Chief ...

LogicBio Therapeutics to Present at the Jefferies Virtual Healthcare Conference

1mon ago, source: YAHOO!

LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare ...

LOGC LogicBio Therapeutics, Inc. Common Stock

29d ago, source: Nasdaq

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

LogicBio Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders

1mon ago, source: GlobeNewswire

LEXINGTON, Mass., June 05, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.